Igarashi, Yuka
161  results:
Search for persons X
?
1

MMP1, IL-1β, sTNFR-1, and IL-6 are prognostic factors for p..:

Nagasaka, Hirotaka ; Kishida, Takeshi ; Kouro, Taku...
International Journal of Clinical Oncology.  29 (2024)  6 - p. 832-839 , 2024
 
?
2

Circulating IL-6 and not its circulating signaling componen..:

Nakahara, Yoshiro ; Kouro, Taku ; Motoyama, Satoru...
Frontiers in Cell and Developmental Biology.  11 (2024)  - p. , 2024
 
?
3

Clinical roles of soluble PD-1 and PD-L1 in plasma of NSCLC..:

Himuro, Hidetomo ; Nakahara, Yoshiro ; Igarashi, Yuka...
Cancer Immunology, Immunotherapy.  72 (2023)  8 - p. 2829-2840 , 2023
 
?
5

Machine learning for prediction of immunotherapeutic outcom..:

Wei, Feifei ; Azuma, Koichi ; Nakahara, Yoshiro...
Journal for ImmunoTherapy of Cancer.  11 (2023)  7 - p. e006788 , 2023
 
?
6

Clinical significance of peripheral TCR and BCR repertoire ..:

Nakahara, Yoshiro ; Matsutani, Takaji ; Igarashi, Yuka...
Cancer Immunology, Immunotherapy.  70 (2021)  10 - p. 2881-2892 , 2021
 
?
7

C-reactive protein at 1 month after treatment of nivolumab ..:

Noguchi, Go ; Nakaigawa, Noboru ; Umemoto, Susumu...
Cancer Chemotherapy and Pharmacology.  86 (2020)  1 - p. 75-85 , 2020
 
?
10

Single Cell-Based Vector Tracing in Patients with ADA-SCID ..:

Igarashi, Yuka ; Uchiyama, Toru ; Minegishi, Tomoko...
Molecular Therapy - Methods & Clinical Development.  6 (2017)  - p. 8-16 , 2017
 
?
11

Illusory visual-depth reversal can modulate sensations of c..:

Igarashi, Yuka ; Omori, Keiko ; Arai, Tetsuya.
Experimental Brain Research.  235 (2017)  10 - p. 3013-3022 , 2017
 
?
 
1-15